Naming Novo Names: Who Could Be the Next CEO?
With Novo Nordisk preparing for the succession of Lars Fruergaard Jørgensen as CEO (previous FENIX insight), the key question now is: who will take on the role? In Novo’s investor call to discuss its leadership transition plans, the company emphasized that its strategy has not changed and that it will continue to execute its current plans. As such, this seems to suggest that its next CEO may be more likely to fall in line with its previous patterns (e.g., internal hire) rather than someone who is viewed as more transformative. Below, FENIX presents a selection of both internal and external candidates as well as an assessment of the likelihood that they are on the CEO search committee’s short list.
About The Author
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.
If you receive our email blasts, you already have an account. Log in now
You can read the article’s full content online after purchase.